Quick Reference
- Scientific Rating
-
5.0/ 5.0
- Primary Mechanism
- Inhibition of pro-inflammatory eicosanoid synthesis (prostaglandins and leukotrienes)
- Standardized Form
- Ethyl ester or Triglyceride form
Eicosapentaenoic acid (EPA) is a polyunsaturated omega-3 fatty acid found in cold-water fish. Clinically, EPA is distinguished from DHA by its superior ability to reduce cellular inflammation and lower serum triglycerides. It competes with arachidonic acid in the cyclooxygenase pathway, thereby reducing the production of pro-inflammatory prostaglandins, making it a primary target for cardiovascular and mood-support formulations.
Table of Contents
Clinical Summary
Extensively validated in clinical trials for reducing triglyceride levels, supporting cardiovascular health, and improving symptoms of major depressive disorder when used in high ratios relative to DHA.
Dosage Guidelines
1,000mg to 2,000mg daily for targeted cardiovascular and mood support.
Safety & Side Effects
Mild gastrointestinal upset, "fish burps," and potential increased bleeding risk at extreme doses.
Known Interactions
Can interact with blood-thinning medications like warfarin or aspirin.
Scientific References
- 1
- 2
Medical Disclaimer
The information provided in this clinical review is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
*These statements have not been evaluated by the Food and Drug Administration (FDA). This product or ingredient is not intended to diagnose, treat, cure, or prevent any disease.
Always consult your physician or other qualified health provider with any questions you may have regarding a medical condition, or before beginning any new diet, fitness, supplement, or treatment regimen, especially if you have pre-existing medical conditions or are taking prescribed medications.
